Impact of the Change in Administration on FDA’s Regulation of Devices and Digital Health

Wednesday, March 10, 2021
01:00 PM - 02:00 PM Eastern Standard Time
12:00 PM - 01:00 PM Central Standard Time
10:00 AM - 11:00 AM Pacific Standard Time

During this webinar, we’ll discuss what we are paying attention to with the Biden administration Food and Drug Administration (FDA).

Topics will include:

  • Changes in FDA leadership and culture
  • Developments in FDA’s approach to regulating LDTs and digital health
  • FDA enforcement activity, both during and after the pandemic
  • The much anticipated release of FDA’s alignment of the Quality System Regulation (QSR) to ISO 13485:2016 


To access slides from this webinar, please contact Erin Beck.

CLE credit: CLE credit in CA, IL, NY, PA, TX, and VA is currently pending approval. Credit in CT, FL, and NJ is pending approval (via reciprocity).